Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
AstraZeneca and Amgen to present detailed results from Phase III AMAGINE-1™ study evaluating brodalumab in patients with moderate-to-severe plaque psoriasis
-
MOVENTIG® approved in the European Union for opioid-induced constipation
-
Jury verdict favours AstraZeneca in Nexium antitrust litigation
-
New Drug Application for IRESSA accepted by US Food and Drug Administration
-
AstraZeneca and Eli Lilly and Company initiate pivotal clinical trial for patients with early Alzheimer’s disease
-
AstraZeneca to collaborate with Cancer Research UK in screening for new cancer medicines at the AstraZeneca MRC UK Centre for Lead Discovery
-
MedImmune completes acquisition of Definiens
-
Amgen and AstraZeneca announce positive results from third and final pivotal Phase III study of Brodalumab in patients with moderate-to-severe plaque psoriasis
-
Duaklir® Genuair® approved in the European Union for chronic obstructive pulmonary disease
-
AstraZeneca launches and prices a €750,000,000 7 year bond issue
Latest articles and press releases
All of our latest press releases and articles are available to explore
